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Abstract 
 In March of 2012 the Department of Health and Human Services released 
the proposed rules for stage 2 of meaningful use; in addition to increasing the 
requirements for electronic health record implementation, the rules newly require 
that patients have continuous electronic access to their personal health 
information and lab results, a functionality accomplished by most providers 
through the use of “health portals” or “personal health records.”  The purpose for 
the rules is to improve the efficiency and quality of care delivered, both clinically 
– improved patient outcomes - and on a systems level – reduced resource 
utilization.  Little research exists on the clinical or systems level usefulness of 
health portals, yet stage 2 meaningful use, if approved, will greatly accelerate 
widespread portal implementation. 
 We performed a retrospective analysis of University of North Carolina 
(UNC) Emergency Department (ED) billing data to examine an association 
between access to the UNC Family Medicine health portal and inappropriate ED 
utilization.  We used a subset of Ambulatory Care Sensitive Conditions, published 
by the Agency for Healthcare Research and Quality, to define inappropriate ED 
use.  We examined mean total ED visits, mean inappropriate ED visits, and the 
mean ratio of inappropriate to total ED visits. 
 We observed no association between access to a health portal and either 
total or inappropriate ED utilization.  The null findings highlight that the mere 
presence of a technology, especially one with little intrinsic functionality beyond 
  
 
facilitating communication, does not ensure a change in resource utilization. If 
health portals as a technology do have a system level effect, it is likely moderated 
by variables not captured in our exploratory study, such as physician engagement 
or software usability. 
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Introduction 
The Health Information Technology for Clinical and Economic Health Act 
(HITECH) was passed in 2009 as a part of the American Reinvestment and 
Recovery Act (ARRA), known generally as the “stimulus bill”.  Central to 
HITECH is “meaningful use”, legislation providing financial incentives to 
providers who not only purchase electronic health records (EHR) but use them in 
a way that lowers the cost and improves the quality of care.  The Notice of 
Proposed Rule Making (NPRM) for stage 2 of meaningful use requires that all 
providers ensure that patients have continual electronic access to their personal 
health information (PHI), an objective being fulfilled by the widespread 
implementation of internet based patient portals or personal health records (PHR).  
Personal health records and patient portals are ways for patients to see 
their health information, communicate with their physicians, and perform simple 
health care transactions such as scheduling an appointment or refilling a 
prescription.  Though early adopters have already begun implementing these 
technologies, the emerging developments of the meaningful use criteria combined 
with significant incentive payments will greatly accelerate the process.  Although 
we hypothesize that continual electronic access to PHI is beneficial to patient 
outcomes and quality of care, no data as yet demonstrate clinical benefits or cost 
savings (Tenforde, Jain, and Hickner 2011, 351-354). 
Portals have theoretical benefits both on the individual level, with 
improved clinical outcomes, and on the system level via improved care 
coordination, reduced ED utilization, and fewer inpatient visits.  The very few 
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extant randomized trials of portal technology focus primarily on the clinical utility 
of the technology; no studies directly examine systems level outcomes of portal 
technology (Archer et al. 2011, 515-522; Nazi et al. 2010, 62-67). 
The emergency department (ED) has become a known repository for 
failure in the health care system.  Lack of convenience, no prior provider 
relationships, or the inability to schedule a prompt appointment lead patients to 
seek primary care in the emergency room or to seek emergent care for an 
exacerbation of a process easily managed in an ambulatory setting (Shesser et al. 
1991, 743-748). Theoretically, a patient portal is both a channel for provider 
access and a mechanism for patient engagement.  If portals can make it easier for 
patients to access their PHI or contact a provider, they may alter when and where 
patients seek care. 
The UNC Family Medicine practice has a proprietary patient portal that 
provides web-based scheduling, secure messaging with providers, and access to 
self-care information – common features of most health portals and PHR.  We 
provide a preliminary exploration of associations between portal access and 
appropriate emergency room utilization, and commence an examination of the 
consequences of internet portals, a significant technology in the context 
meaningful use criteria, from a systems perspective.   
This and larger future studies can provide useful data for health care 
decision makers both in demonstrating potential effects on the cost of care as well 
as highlighting variables that moderate the utility of new technology.  
Furthermore, our study joins the growing number of necessary inquiries into the 
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consequences of national policy implemented in a variety of clinical and 
organizational contexts (Archer et al. 2011, 515-522), all asking the same 
essential question: “Is meaningful use meaningful?” 
Background  
The U.S. health care system remains the most expensive in the world yet 
does not produce outcomes proportional to its spending(World Health 
Organization 2000; Anderson et al. 2003, 89-105).  The Institute of Medicine’s 
landmark report, To Err is Human, estimated that 44,000 to 98,000 patients die 
each year from preventable medical error (Kohn, Corrigan, and Donaldson 2000). 
As medical knowledge grows and increased specialization further fragments care 
processes, it is natural to expect medical errors to continue or even to increase. 
Even though health care is an industry dependent on the management and 
interpretation of data, it has been slow to adopt modern information technology; 
as of 2008 only 17% of providers and 12% of hospitals had implemented 
EHR.(DesRoches et al. 2008, 50-60) The major preoccupations of health care 
delivery have changed from provision of acute care to the management of chronic 
disease, requiring the intensive coordination of many providers.  Efficient 
communication is essential to reductions of both redundancy and error – a process 
made difficult by the persistence of paper charting. 
the delays in HER implementation have many causes.  The fee-for-service 
payment structure creates a context in which investment in technology is against 
the financial self-interest of most providers, and providers are reluctant to invest 
in complex systems they lack the expertise to evaluate.  Logistical barriers also 
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exist: many benefits of EHR are realized through information sharing between 
providers, a complex functionality requiring the collaboration of stakeholders who 
are often direct competitors as the system is organized now.  Finally, with new 
forms of information sharing come a new set of patient concerns about the 
confidentiality and security of their PHI, a regulatory issue beyond the scope of 
any one provider or EHR vendor.(Blumenthal 2011, 2323-2329; Tang et al. 
2006b, 121-126) 
The HITECH act combines up to $27 billion dollars in incentives with the 
threat of reduced Medicare and Medicaid reimbursement to catalyze the 
widespread adoption of EHR; it empowers the Office of the National Coordinator 
of Health Information Technology (ONCHIT) to create an array of programs that 
provide a comprehensive, multi-pronged response to the distinct barriers that have 
prevented a market-driven adoption of HIT thus far.  Included in the bill are 
strategies such as training a new body of HIT experts, developing state-level 
Regional Extension Centers, and modifying the Health Insurance Portability and 
Accountability Act (HIPAA) to be more stringent.  However, the central 
provision, that which all other components of HITECH directly or indirectly 
support, is “meaningful use.” 
Meaningful use, defined and implemented by the department of Health 
and Human Services (HHS), guides the disbursement of funds to physicians, via 
Medicare and Medicaid, initially for EHR implementation and eventually, in later 
stages, for demonstrated improvement in clinical outcomes and quality measures.  
It is a strategy without academic, legal, or political precedent.   
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The initial bill authorized a disbursement of up to $44,000 for Medicare 
dominant provider groups and up to $63,750 for Medicaid dominant provider 
groups, each payment distributed over a 5 year period; hospitals were offered 
from $2million to $10 million.  The incentives are awarded in annual increments, 
the amount of each gradually reducing over several years, finally to terminate in 
2015 for Medicare and 2017 for Medicaid. (Blumenthal 2011, 2323-2329) 
Stage 1 involves meeting approximately 25 criteria –varying slightly 
between physicians and hospitals – among which are a set of required “core” 
objectives and optional “menu” objectives.  Providers must demonstrate 
meaningful use by the end of 2012 to be eligible for the full incentive amount; 
planned deadlines for stage 2 and stage 3 are 2013 and 2016 respectively, and 
these deadlines must be met to continue to receive payments.  The objectives for 
future stages are yet to be written; stage 2 was released in March, 2012 as a 
Notice of Proposed Rule Making (NPRM) and at this writing is in the 60 day 
window of public commentary. 
The changes and requirements in the NPRM demonstrate a balance of 
clear movement forward towards goals of demonstrating clinical and quality 
improvement with restraint to ensure that objectives remain feasible for providers 
still struggling to adopt basic EHR.  As its own Health IT web site 
(http://www.healthit.gov/providers-professionals/meaningful-use-definition-
objectives) makes clear in the framining of definitions, the central thrust of 
meaningful use was to promote specific functionalities previously demonstrated 
to provide clinical and quality benefits, including computerized prescribing with 
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decision support, quality benchmark reporting, and health information exchange. 
The proposed stage 2 rules in the Notice incrementally increase requirements in 
each of the three domains.   
Computerized provider order entry (CPOE) requirements have been 
expanded so that most orders now must occur electronically.  A large list of 
quality measures have been suggested as candidates for required reporting to 
achieve meaningful use.  Initially, stage 1 only required that providers purchase 
EHR with the ability to share information, but stage 2 requires that providers 
actually use the functionality.  Notably, the NPRM has increased the requirement 
for patients to access their own PHI; the revised stage 1 and proposed stage 2 
rules require that 50% of patients have the ability to view, download, and transmit 
their data and that 10% actually do so.  This requirement, if passed, will 
effectively mandate that providers implement a patient portal or PHR. 
The American Health Information Management Association (AHIMA) 
defines Personal Health Records (PHR) as an “an electronic lifelong resource of 
health information needed by individuals to make health decisions.  Individuals 
own and manage own and manage the information in the PHR, which comes from 
healthcare (sic) providers and the individual.  The PHR is maintained in a secure 
and private environment, with the individual determining rights of access.  The 
PHR does not replace the legal record of any provider” (Tang et al. 2006a, 121-
126). Older versions of PHR were populated manually by patients but more 
recent, “tethered” PHR automatically extract information from provider’s records.  
Patient portals are similar to PHRs in that they provide patients with online access 
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to their PHI, and they also have additional functionalities such as scheduling and 
communication.  Portals, however, are often directly associated with a provider, 
where as a PHR is often independent and may interface with several providers.  
Currently, the distinction between PHR and portals, both in clinical 
implementation and academic literature, is minimal, as most PHR or portals are 
implemented and managed by a single provider. 
 
Methods 
We conducted a retrospective cohort study using an original dataset 
generated by merging data extracted from two databases: the UNC Physicians and 
Associates (P&A) billing database and the UNC Family Medicine Patient 
Communication Tracking System (PCTS).  Our period of interest for the study, 
the time for which we tracked ED use, was between January 1
st
 2011 and January 
1
st
 2012.  Our query was designed to capture a population of patients that had 
been seen in the 18 months prior to the study and were still active UNC Family 
Medicine patients during the study. 
To establish an initial study population, we queried the P&A database for 
all patients who had visited the UNC Family Medicine Clinic (FMC) at least once 
from July 1
st
 2009 to January 1
st
 2010 and at least once from January 1
st
 2011 to 
January 1
st
 2012.  Included in this query were demographic variables and ICD-9 
diagnostic codes pertaining to baseline health status (Appendix 1).  We performed 
a sub-query of the resultant list of Family Medicine patients for all ED visits made 
by these patients during the period of interest – January 1st 2011 to January 1st 
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2012.  This dataset included ICD-9 diagnostic codes forming the basis for our 
outcome measure.  For data pertaining to portal access, we queried the UNC 
Patient Communication Tracking System, a dataset that tracks multiple vectors of 
communication between patients and physicians.  We examined all instances of 
portal access by our patient sample between the dates of January 1
st
 2010 and 
January 1
st
 2011. 
The first author coded the data for the FMC by ICD-9 codes to indicate the 
presence or absence of three chronic diseases:  Congestive Heart Failure, Diabetes 
Mellitus Type II, and Hypertension.  The first author also coded data for ED visits 
to indicate if a visit included a diagnostic code we had determined to be an 
inappropriate use of the ED because it reflected one of the ambulatory-sensitive 
conditions we used to discriminate between causes of ED visits (see below).  The 
PCTS data were reduced to a unique list of medical record numbers, indicating 
those patients that had used the portal at least once during the aforementioned 
time period.  The FMC, ED, and PCTS datasets were then merged using the 
medical record number as a common unique identifier.  We performed statistical 
analysis on the resulting merged data to determine whether those who had used 
the patient portal were less likely to appear in the ED with an ambulatory-
sensitive condition  (See Appendix 1for further explanations of variable creation) 
DATA 
Population:  We chose to define the study population as all FMC patients 
seen 18 months prior to the study period and at least once during the study period 
who had also visited the ED at least one time during the study period.  This was a 
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smaller subset of the larger, general FMC population.  We chose to define the 
study as such to improve the possibility of detecting a signal that indicated an 
association between portal access and inappropriate ED use.  The weakness of 
this strategy is that the mean values for many of our outcomes will be higher than 
the mean values of the entire FMC population, limiting our ability to interpret the 
absolute values of the outcomes measured – our choice has created something of a 
ceiling effect. 
Independent variable:  The UNC Family Medicine portal provides three 
functions: scheduling, secure messaging, and access to self-care information.  
This varies from a traditional portal or PHR in that the patient does not have 
access to personal health information.  The UNC Family Medicine portal, in 
providing secure messaging, serves as an example of electronic access to a 
provider, a common, meaningful feature of many portals or PHR.   
Dependent variable.  To define the outcome of “inappropriate” emergency 
room use we used a subset of the list of Ambulatory Care Sensitive Conditions 
(ACSC) published by the Agency for Healthcare Research and Quality (AHRQ ). 
ACSC are conditions for which appropriate ambulatory care can prevent or 
reduce inpatient admissions.  From the list we selected those conditions that were 
pertinent to adults, equally applicable to men and women, and were diagnoses 
with a care- seeking component – in which accessing a provider earlier may have 
prevented the presentation to the emergency room.  The entire list of AHRQ 
ACSC can be found in Appendix 1, Table 3; our list of outcome conditions 
includes severe ENT, pulmonary conditions including COPD, bacterial 
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pneumonia, and asthma; CHF, a particular target of CMS readmission reduction 
policies; hypertention and angina, cellulitis, conditions related to diabetes, and 
dental conditions.  All these conditions should, ideally, be managed with 
ambulatory care such that their symptoms or exascerbations do not lead to ED 
visits. 
Defining inappropriate ED use is difficult; there is no standard method in 
the literature and significant variation accompanies different attempts to quantify 
inappropriate visits (Lowe and Bindman 1997, 133-136).  We chose to use 
ACSCs as the basis for our outcomes measure because this approach to defining 
unnecessary ED use relies on conclusions by the federal agency charged with 
assuring quality of care, uses ICD-9 billing codes, and has historic use in the 
literature (Oster and Bindman 2003, 198). 
The challenge of using ACSC as a sentinel for inappropriate ED use is that 
these conditions can be prevented by early primary care.  The exascerbations of 
the conditions being tracked with the ACSC list are actually appropriate for the 
emergency room, but it is inappropriate that the exascerbations ever occurred.  
Several of the ACSC conditions are related to receiving appropriate 
immunizations or basic preventive care.  We chose to select conditions that would 
result from either the inappropriate management of chronic disease or emergent 
conditions that are usually preceded by a sub-acute presentation treatable in an 
ambulatory setting, such as bacterial pneumonia. 
Using ICD-9 billing codes to evaluate diagnoses, we created a demanding 
test of inappropriate use by coding any visit in which the primary diagnosis was 
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one of the ICD-9 codes in our ACSC subset as “inappropriate.”  We created a 
variable that recorded the total number of ED visits per patient, another variable 
that recorded the total number of inappropriate visits per patient, and a final 
variable,  the ratio of inappropriate ED visits to total ED visits.  We then created a 
further summary dummy variable indicating that a patient had inappropriately 
used the ED at least once. 
Our goal for the study was to detect a signal indicating an association 
between ED use and portal access, not to quantify inappropriate ED use or 
establish causal direction.  We chose four different variables to track ED use in 
order to provide an opportunity to triangulate our results.  If multiple outcomes all 
demonstrate a similar coherent signal, the observation is less likely to be random.  
Conversely, if all four methods of examining the outcome demonstrate a null 
finding, the observation that no association exists is strengthened. 
Fidelity of the outcome measurement.  The outcome we created was not 
intended to capture all instances of inappropriate ED use, as any attempt to do so 
would be questionable validity, and be so complicated as to be outside of the 
scope of the study.  Rather we attempted to construct a highly correlated proxy for 
the amorphous concept of inappropriate ED use.  Additionally, the measurement 
process of the outcome is complicated by a lack of reliability in how ICD-9 codes 
are documented in the UNC Physicians & Associates billing database.  Diagnoses 
are categorized into primary and secondary diagnoses for each ED visit.  Our data 
only included the primary diagnosis recorded at the time of each visit. 
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It is important to emphasize that the primary endpoints are only 
interpretable in the context of relative comparisons; they are not adequate to 
quantify an absolute number of unnecessary visits.  It is unlikely that the coding 
of ICD-9 data varied systematically between the control and intervention group - 
as those coding the data were unlikely aware of portal status.  However, our 
method only captures a subset of ED visits determined by ACSC criteria to be 
inappropriate and likely underestimates the actual level of inappropriate.   
Controls:  Age was calculated from the date of birth and we included 
other demographic information – sex, race, payer status – as recorded in the 
original dataset. Payer status was our only option for creating a proxy for the 
patient’s socio-economic status and education.  This proxy is admittedly coarse, 
and thus likely understates the potential effectiveness of portal use.  Although 
Medicare and private insurance patients can vary significantly in income, 
education, and internet access, Medicaid insurance likely corresponds to lower 
income and less education.  Demonstrating an effect independent of Medicaid 
status, thus, will be strongly suggestive that at least part of the effect is also 
independent of income and education.  Internet access is quickly becoming 
ubiquitous, but discrepancies in access by age, socioeconomic status, and race 
may persist.  We do not directly measure internet access; we know that it may 
underlie any association between other demographic variables and portal use 
In addition to the important demographic, literacy, and internet access 
variables we cannot directly measure, we also lack direct measures of health 
status and patient engagement.    We control for the baseline presence of three 
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chronic diseases: Hypertension, Diabetes Mellitus Type II, and Congestive Heart 
Failure.  Those with such diagnoses may have disproportionately worse health 
status than those in the other arm of the study, for whom we do not control for 
other chronic disease. Poor health may be associated with greater use of the ED in 
itself, and it may be associated with greater rates of portal access because sick 
patients have a greater need for health care resources.  Though total ED visits 
could also be used as a measure of health status, it is also a variable influenced by 
a propensity to seek health care.  Recording the presence of chronic disease 
seemed to be a more direct measurement of the variable of interest. 
 
Analysis 
 
We examined differences in mean values or frequencies between the 
portal access and non-portal access groups on each of the demographic and health 
status variables with 2-sample t-tests for continuous variables and a Pearson’s chi-
square test for dichotomous or categorical variables.  For those categorical 
variables with more than two values, each value of the variable was analyzed 
separately as a dichotomous variable using Pearson’s chi-square. 
Using a binary variable indicating one or more inappropriate visits to the 
ED, we calculated the unadjusted risk ratio of inappropriate ED use by portal 
access.  Our goal was to examine the isolated association of portal access, our 
intervention, on inappropriate ED use, the outcome.  We performed two multiple 
linear regressions, a full model adjusting for all demographics and a reduced 
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model adjusting for only those demographic variables with a potential 
confounding effect,  for each of three outcomes: total ED visits, total 
inappropriate ED visits, and a ratio of inappropriate ED visits to total ED visits.  
The sequence of analysis for each outcome variable was identical and is described 
below. 
Prior to running the model we created dummy variables for the categorical 
variables with more than 2 categories - race and payer status.  We initially ran a 
linear regression for the effect of portal access on the outcome of interest, 
adjusting for all measured demographic variables.  We noted the Beta value for 
portal access.  We then used bivariate analysis to explore the association of any 
other measured variable to the intervention, portal access; we used a 2 sample t-
test for continuous variables and a Pearson’s chi-square test for categorical 
variables.  For those variables with more than 2 categories, we created binary 
dummy variables for each value of the variable and used Pearson’s chi-square test 
to examine association between the newly created dummy variable and the 
outcome of interest.  We then reran a multiple linear regression with a reduced 
model, including only those variables that demonstrated an independent 
association with the outcome of interest, and excluding African American race 
and Medicaid payer status, since these two variables showed little association 
with portal access.  We confirmed that the beta and the calculated mean in the 
reduced model did not differ from those in the full model.  We reported the mean 
values for the outcome of interest by portal access, the 95% confidence interval, 
and the associated p-value. 
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Results 
Our study population, Family Medicine patients who had also visited the 
ED between January 1
st
 2011 and January 1
st
 2012, totaled 2,977; this is only 
17.05% of Family Medicine patients in the period.  Thirty percent of Family 
Medicine patients had accessed the portal at least once during the period (patients 
manually enter their medical record numbers, and we found that we could not 
match an additional 6.7% of patients who had used the portal to a valid medical 
record number in the Family Medicine Clinic dataset, so the actual number of 
portal users may be closer to 40%). 
Most measured variables did significantly vary by portal access.  As we 
have noted, the two exceptions were African American race and Medicaid payer 
status. (Table 1)  Portal users were more likely to be older, female, white, insured 
by Medicare, and have a chronic disease.  Those who did not use the portal were 
more likely to be self- or privately insured.   Though the unadjusted frequency of 
inappropriate ED use did not vary significantly by portal access, it is notable that 
a fifth of the patients in this subsamplehad used the ED for a diagnosis we flagged 
as inappropriate.  
The unadjusted risk ratio of inappropriately using the ED at least once 
lacked statistical significance (RR = 1.08; 95% CI  0.93 – 1.25).  We ran multiple 
linear regressions for each of the three outcomes of interest controlling for all 
other measured variables and did not find astatistically significant correlation 
between portal access and the outcomes: total ED visits (β = 0.131, P=0.123), 
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total inappropriate ED visits (β = -0.004, p=0.866), and the ratio of inappropriate 
to total ED visits (β = -0.009, p=0.425).  In the three reduced-model linear 
regressions, controlling only for those variables that demonstrated an association 
with portal access, a lack of statistically significant correlation persisted across all 
measured outcomes; the beta values and statistical significance were unchanged 
for all three variables. 
The adjusted mean values calculated by each linear regression also did not 
vary significantly.  Portal users had more, but not significantly more, total ED 
visits than did those who had not used the portal (Portal: 2.02, No Portal: 1.88; 
p=0.123), and we found no significant variation in mean inappropriate ED visits 
(Portal: 0.239, No Portal: 0.243; p=0.866) or the mean ratio of inappropriate ED 
visits to total ED visits (Portal: 0.120, No Portal: 0.130; p=0.420). 
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Table 1: Distribution of demographic variables by intervention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical significance calculated using 2 sided t-tests for continuous variables and Pearson’s Chi-square for categorical 
variables. 
*p<0.05 
**p<0.0001 
 
 
Table 2. Risk Ratio of 1 or more inappropriate ED visits by portal access 
Variable RR 95% CI 
1 or more inappropriate ED visits  1.08 0.93 – 1.25 
 
 
Table 3: Adjusted* Mean or Percent of ED visits comparing Portal Access to No Portal Access 
Outcome Portal Access 95% CI No Portal 
Access 
95% CI p value 
Total ED visits  2.02 1.88 – 2.13 1.88 1.78 – 1.97 0.1231 
Inappropriate ED visits 0.239 0.21 – 0.27 0.243 0.217 – 0.269 0.866 
Inappropriate/Total visits** 0.120 0.102 – 0.138 0.130 0.116 – 0.143 0.42 
* based on beta estimates of a multiple linear regression model controlling for age, sex, payer status, race, and baseline health 
status 
**proportion of inappropriate ED visits to total ED visits 
 
 
 
 
 
Demographic Total No Portal Access 
(proportion or 
mean) 
Portal Access 
(proportion or mean) 
Age (mean) ** 48.37 45.18 53.74 
Sex 
     Male ** 
     Female 
 
38.02 
61.98 
 
41.39 
58.61 
 
32.37 
67.63 
Race 
     White* 
     African-American 
     Asian * 
     Other** 
 
53,85 
38.29 
  1.68 
  6.18 
 
51.58 
38.55 
  2.04 
  7.83 
 
57.64 
37.86 
  1.08 
  3.42 
Payer 
     Self-Pay* 
     Private** 
     Managed Care* 
     Medicare** 
     Medicaid 
 
19.92 
27.51 
  7.99 
27.38 
17.20 
 
21.45 
30.19 
  9.06 
21.18 
18.12 
 
17.36 
23.02 
   6.21 
37.77 
15.65 
Baseline Health Status 
     CHF** 
     HTN** 
     DM Type II** 
 
  2.65 
32.55 
15.62 
 
 1.34 
24.61 
10.78 
 
  4.86 
45.86 
23.74 
1 or more inappropriate ED 
visit 
19.52 18.93 20.50 
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Discussion 
The lack of significant association between the primary outcomes of the 
study – total ED use, total inappropriate ED use, and the ratio of inappropriate to 
total ED use – and portal access provides useful insight into the implementation 
of portals. The data demonstrate that whatever care process led to the overall rate 
of inappropriate ED visits in the Family Medicine population, the presence or 
absence of a portal did not meaningfully alter that process for the sample as a 
whole.  Without knowing much more about the patients who can and do use a 
portal, we cannot say that the mere presence of a portal can change outcomes. 
Two conclusions can stem from our observations: portals do not have the 
ability to modify rates of inappropriate ED use, or portals do have the ability to 
modify ED use but that capacity is unrealized in this instance.  A similar 
conclusion can be made by most studies of portals and PHR with null findings.   
A portal is a channel, with little implicit unique value; it primarily facilitates care 
process that could occur in other, more resource intensive venues, such as a face-
to-face visit; it has the potential to deliver a similar care process but at greater 
convenience and, potentially, lower cost, to the provider and patient. 
If a provider does not have an existing care process that can produce an 
outcome – be it reduced inappropriate ED visits or improved HbA1C – it is 
unlikely that the presence of a portal will do so.  If a care process has been shown 
to generate outcomes but a provider refuses to use the portal, or the patient refuses 
to use the portal, then the presence of the portal will not produce meaningful 
change.  A portal likely does not offer independent utility but rather provides a 
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way to practice a style of care that may be otherwise financially or logistically 
infeasible without electronic communication.  
Many physicians are concerned that technology such as health portals will 
have a poor return on investment (DesRoches et al. 2008, 50-60); this is in part 
due to fee-for-service financial arrangements that do not reimburse physicians for 
efficiency, or for generating administrative and technologic investment.  Though 
meaningful use and the accompanying funds generate a temporary financial 
incentive to drive the purchase and implementation of technologies like health 
portals, the underlying payment structure causing provider reluctance to invest in 
EHR and related technologies still exists.  Physician involvement will likely be 
the minimum required to remain eligible for incentive funds.  However, without 
genuine physician investment it is unlikely that many technologies, especially 
those that primarily facilitate communication and information sharing between 
patient and providers will produce meaningful benefit. 
Though by no means conclusive, the findings and results of other studies 
are suggestive that measuring provider involvement and attitudes is important 
(Grant et al. 2008, 1776; Wagner et al. 2012; Green et al. 2008).   Our study, 
similar to other retrospective analyses of portal based interventions, did not 
capture physician engagement or perception; nor could it parse the potential 
differences among patients – for example, the possibility that older women, who 
are (somewhat surprisingly) more likely to be portal users, are also more likely to 
be worried about symptoms, and therefore more likely to use both the portal and 
the ED. 
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The common challenge of most PHR and portal studies, especially those 
of observational design, is the confounding relationship of patient engagement.  
The theoretical causal pathway of portal benefit is that a portal generates patient 
engagement that in turn causes improved health behaviors – such as improved 
self-care or better use of health care resources.  However, patients that are 
engaged at baseline may more likely to use a health portal; portal access may act 
merely as a marker of patient engagement rather than a cause of it.  Our inability 
to account for patient engagement with our data is a significant shortcoming.  
Though we did not observe an effect, if we had, the effect may have been caused 
not by the intervention, but rather a baseline difference between the two cohorts, 
as we have suggested.  
The usability of technology is a significant, but unaddressed variable that 
moderates the usefulness of technology.  As mentioned previously, the term 
“health portal” is a broad term encompassing a broad range of functions; across 
varying health portals, designed by a multitude of vendors, is significant 
heterogeneity in design and quality.  The nuances of the user interface of a portal 
both patient-facing, and provider-facing can dictate if a technology is useful or 
cumbersome.  The implementation of poorly designed software, driven by policy 
requirements, is a significant risk of the meaningful use strategy; yet software 
design is infrequently addressed in studies of portals or PHR. 
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Conclusion 
Our study corresponds to other research examining portal or PHR use in 
that it did not find a significant outcome clearly attributable to the presence of a 
portal (Tenforde, Jain, and Hickner 2011, 351-354). However, the lack of findings 
does not conclusively demonstrate that portals are valueless.  Rather, from the 
process of our exploration, it is the unanswered questions that inform future 
research.  Baseline patient engagement, physician engagement, and the design of 
technology are important variables to capture when evaluating the utility of a 
portal.  The mere presence of a technology tells us nothing about how patients and 
providers use it. 
Meaningful use is reaching the end of the first stage, the stage of 
purchasing and implementing EHR.  Only future stages will reveal if policy has 
the ability to generate meaningful outcomes from “meaningful use.”  Some have 
pointed to the lack of meaningful change in clinical or quality oriented outcomes 
as evidence of the ineffectiveness of meaningful use, but that conclusion is likely 
premature.  It is unrealistic to assume that the presence of a technology itself will 
produce change.   
The role of the physician is important in the success or failure of 
meaningful use policy, but without payment reform, providers attempting to 
implement technology as required by meaningful use, will be doing so against 
their financial self-interest.  Though meaningful use incentives offset the cost, the 
larger financial context for providers is unchanged; there is a risk that provider 
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engagement with technology will be superficial during the meaningful use process 
and recede once the incentive funds have been fully disbursed. 
Stage 1 requirements of meaningful use are such that providers can 
achieve objectives without significantly modifying clinical processes.  The risk is 
that the true burden of meaningful use will only become apparent in the future 
stages.  Currently providers may not have to grapple with usability issues, seeing 
the collection of basic data as a minor inconvenience.  However, when later 
meaningful use stages begin to require demonstrated change in outcomes, a 
process that will require a significant cultural shift and integration of technology 
into the clinical workflow, more serious challenges may emerge. 
The lack of a broader financial context that rewards physicians for 
expending administrative effort to leverage technology and streamline care 
combined with a distinct absence of focus on user interface and product design 
from HIT vendors, may create a scenario in which providers reluctantly interface 
with cumbersome, or even worse, error-ridden, technology.  Meaningful use 
criteria themselves, far from pushing health care into the 21
st
 century, can burden 
the system with unrealistic expectations and drive the national implementation of 
unrefined software.   
The true challenge of meaningful use is in the cultural shift that must 
occur within practices, in which technology is embraced as an integral part of 
clinical care.  It is unlikely that a set of criteria, however comprehensive, can 
achieve this in isolation.  However, HITECH does include other programs to 
provide individualized, ground-level support, such as regional extension centers 
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and a newly trained body of HIT experts.  Meaningful use and the accompanying 
financial incentives open a window in which providers are willing to invest, 
however reluctantly, in EHR and other technology.  This space can provide room 
for dialogue in which more meaningful change occurs, not by the adherence to 
objectives but rather through the shifting of provider perspectives toward 
technology as a whole. 
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Methods Appendix 
 
Data collection methods were submitted to and approved by the University of 
North Carolina (UNC) Internal Review Board for clinical research.  Data were extracted 
from UNC Physicians and Associates billing database and the UNC Patient 
Communication Tracking System (PCTS) – a proprietary software that tracks instances 
of communication between patients and providers.  Database queries were executed by 
the data custodians for each database, Sonya Buford and Todd Meath, respectively.   The 
first author was the single coder of the ICD-9 codes used to create the outcome variable 
and is responsible for any errors that may have occurred. 
Table 1: Query date chart 
6/1/2009 1/1/2010 6/1/2010 1/1/2011 1/6/2011 
 UNC P&A Billing Data – ER visits 
 PCTS Data – Portal Visits  
UNC Continuity Clinic – Patient roster  
 
Table 2: Data points collected by dataset 
UNC Family Medicine Clinic UNC Emergency Department Patient Communication Tracking 
System 
Medical Record # Medical Record # Medical Record # 
DOB Date of visit Date of Portal Query 
Date of visit ICD-9 Diagnosis Reason for Portal Query 
ICD-9 Diagnoses   
Insurance Status   
Race   
Sex   
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Table 3: Ambulatory Care Sensitive Conditions and study outcomes 
Diagnosis Comments 
Study 
outcome 
Congenital syphilis [090] 
  
Immunization-related and preventable conditions [033, 037, 
045, 320.0, 390, 391] 
Hemophilus meningitis 
[320.2] age 1 - 5 only 
 
Grand mal status and other epileptic convulsions [345] 
  Convulsions "A" [780.3] Age 0-5 
 Convulsions "B" [780.3] Age >5 
 
Severe ENT infections [382, 462, 463, 465, 472.1] 
Exclude otitis media cases 
[382] with myringotomy 
with insertion of tube 
[20.01] x 
Pulmonary tuberculosis [011] 
  Other tuberculosis [012-018] 
  
Chronic obstructive pulmonary disease [491, 492, 494, 496, 
466.0] 
Acute bronchitis [466.0] only 
with secondary 
diagnosis of 491, 492, 494, 
496 x 
Bacterial pneumonia [481, 482.2, 482.3, 482.9, 483, 
485, 486] 
Exclude case with secondary 
diagnosis of 
sickle cell [282.6] and 
patients < 2 months x 
Asthma [493] 
 
x 
Congestive heart failure [428, 402.01, 402.11, 402.91, 
518.4] 
Exclude cases with the 
following surgical 
procedures: 36.01, 36.02, 
36.05, 36.1, 37.5, 
or 37.7 x 
Hypertension [401.0, 401.9, 402.00, 402.10, 402.90] 
Exclude cases with the 
following procedures: 
36.01, 36.02, 36.05, 36.1, 
37.5, or 37.7 x 
Angina [411.1, 411.8, 413] 
Exclude cases with a surgical 
procedure [01 - 86.99] x 
Cellulitis [681, 682, 683, 686] 
Exclude cases with a surgical 
procedure [01- 86.99], 
except incision of skin 
andsubcutaneous tissue 
[86.0] where it is the only 
listed surgical procedure x 
Skin grafts with cellulitis [DRG 263, DRG 264] 
Exclude admissions from 
SNF/ICF 
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*Those conditions marked with “x” and highlighted in white are the selected outcomes used for the study. 
 
 
Table 4: Index of variables in final dataset 
 
Variable Name Values Description 
patientmrn - 
MR# of the patient, key for 
database 
age 0 -999 Age, in years, calculated from DOB 
sex Male, Female Sex of patient 
patientrace 
White, African American, 
Asian, Other race of patient 
insurance 
Private, Managed Care, 
Medicare, Medicaid, Self Pay FISC payer status 
CHF 0,1 
defines the presence or absence of 
a diagnosis of CHF during any FMC 
visit 
DMII 0,1 
defines the presence or absence of 
a diagnosis of DMII during any FMC 
visit 
HTN 0,1 
defines the presence or absence of 
a diagnosis of HTN during any FMC 
visit 
ED_totalvisit 0 - 99 total ED visits 
Diabetes "A" [250.1, 250.2, 250.3] 
 
x 
Diabetes "B" [250.8, 250.9] 
 
x 
Diabetes "C" [250.0] 
 
x 
Hypoglycemia [251.2] 
 
x 
Gastroenteritis [558.9] 
 
x 
Kidney/urinary infection [590, 599.0, 599.9] 
 
x 
Dehydration - volume depletion [276.5] 
Examine principal and 
secondary diagnoses 
separately x 
Iron deficiency anemia [280.1, 280.8, 280.9] 
Age 0 - 5 only, and examine 
principal and secondary 
diagnoses separately 
 
Nutritional deficiencies [260, 261, 262, 268.0, 268.1] 
Examine principal and 
secondary diagnoses 
separately 
 Failure to thrive [783.4] Age < 1 only 
 
Pelvic inflammatory disease [614] 
Women only denominator - 
exclude cases with a surgical 
procedure of hysterectomy 
[68.3-68.8] 
 Dental Conditions [521, 522, 523, 525, 528] 
 
x 
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ED_totalinapp 0 - 99 total inappropriate ED visits 
ED_itratio 0 - 1 
inappropriate ED visits / total ED 
visits 
edinapp 0,1 
Indicates if patient had 1 or more 
inappropriate ED visits.  Used for 
caculating a risk ratio 
portal 0,1 
Indicates if patient had portal 
access 
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Background Appendix 
 
HITECH act 
The Heath Information Technology for Economic and Clinical Health 
(HITECH), passed in 2009 as part of the American Reinvestment and Recovery Act 
(ARRA), is the legislative catalyst for the current, widespread adoption of electronic 
medical records (EHR).  The bill combines up to $27 billion dollars in incentives with the 
threat of decreased Medicare and Medicaid reimbursement and drives physicians to not 
only purchase health information technology but to use it in a way that may improve the 
quality and efficiency of care.   The many components of the bill respond to distinct 
barriers that have prevented a market-driven adoption of HIT thus far. 
 Information Technology in Health care 
The success of early adopters of EHR, such as Kiser Permanente and the 
Veterans Administration (VA), provided promising empirical backing to the benefits of 
HIT implementation.  Some attribute the transformation of the VA, from a low-quality 
provider to a leader in the provision of high-quality care, to their intense leveraging of 
health information technology.(Jha et al. 2003, 2218-2227)  Additionally, the experience 
of physicians have also been positive, 90% of physician EHR users reported positive 
experiences and could observe specific quality benefits to EHR use. (DesRoches et al. 
2008, 50-60) 
Not all data were uniformly positive and there are safety concerns surrounding 
rapid HIT implementation on a large scale. (Han et al. 2005, 1506-1512; Koppel et al. 
2005, 1197-1203; Koppel and Kreda 2009, 1276-1278; Sittig et al. 2009, 375-377; Sittig 
and Singh 2011, e1042-e1047); It’s also questionable if the benefits demonstrated by 
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custom designed EHR implemented in large health networks are generalizable to late 
adopters purchasing out-of-the-box software packages. (Wu et al. 2006, 742-752)  
However, systematic reviews of the body of literature found an overall benefit to EHR 
implementation mostly realized through specific functionalities such as decision support 
and reduced testing through information sharing.  (Buntin et al. 2011, 464-471). 
Need for Legislation 
Counterproductive financial incentives, product complexity, the need for 
collaborative information exchange, and privacy concerns have each contributed to the 
general industry level resistance towards information technology.  Current market 
dynamics have thwarted the necessary collaboration amongst stakeholders to 
meaningfully implement health information technology.  Policy makers believed that 
each barrier was one that would not resolve spontaneously and would benefit from 
legislative intervention, and the provisions of the HITECH act are structured to respond 
to each challenge. (Blumenthal 2011, 2323-2329) 
Currently, most physicians are paid on a fee-for-service basis and in this form of 
reimbursement providers are dissuaded from investing in efficiency generating processes.  
Installing information technology is an expensive initial investment and, if successful, 
will lead to a process of care that requires fewer tests and fewer visits.  Though payers 
and patients benefit from effective care, providers suffer financially; without significant 
changes to provider reimbursement, it is unlikely that they will spontaneously embrace 
HIT.  Market failures such as this are generally agreed upon by economists as an 
appropriate intervention for government intervention. (Salvatore 2003, 02) 
The variety of health information technology products and their respective 
complexity makes it difficult for providers to be well informed as to the appropriateness 
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of a given product.  Providers are reluctant to invest in systems of which they are 
uncertain and lack the expertise to competently evaluate.  Furthermore, the management 
of IT systems can be complicated and require skills that may not exist in many practices.  
A successful effort to drive the use of EHR in New York City suggests that the 
government can mitigate barriers to expertise through the provision of intellectual 
support. (Mostashari, Tripathi, and Kendall 2009, 345-356) 
Exchanging information between providers is an important but complicated 
capacity of health information systems; it requires standardization and collaboration of a 
myriad of vendors and product developers, many of which are direct competitors to each 
other.  Some policymakers have considered mandating the national use of a single EHR – 
such as the system used for the VA. (Stark 2010, 12)  However, current vendors would 
likely provide strong resistance and many providers have already invested significant 
time and capital implementing other EHR systems.   
The most feasible solution is to the problem of data standardization is to facilitate 
the free exchange of information between multiple platforms.  It is outside the interest 
and financial resources of any one vendor or provider to coordinate standard methods of 
communication and to ensure adherence to those standards.  HITECH supports the 
development an infrastructure, certification process, and regulatory body to manage the 
standardization and sharing of health information. 
Finally, a public concern is ensuring the privacy of health information as it is 
exchanged amongst providers.  There have been reports of breaches in security 
(Department of Health and Human Services, Office for Civil Rights. 2010), and a lack of 
trust on part of the public could quickly undermine the political will for pushing 
information technology forward.  The legislation that now protects health information, 
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the Health Insurance Portability and Accountability Act (HIPAA), needs to be modified 
to account for new ways of sharing and storing health information – such as personalized 
heath records and health information exchanges. 
Implementation 
The HITECH act first established the Office of the National Coordinator for 
Health Information Technology (ONCHIT) and budgeted $27 billion dollars over the 
course of 10 years to support the implementation and subsequent meaningful use of 
EHRs.  Meaningful use will occur in 3 stages over the course of the next 5 years and 
combines two broad strategies: outcomes-based reimbursement and direct payment for 
EHR purchase.   
To reimburse physicians based on demonstrated clinical improvement creates a 
natural incentive to adopt EHRs but may isolate benefits only to clinical care; there are 
other research and public health benefits that would be underemphasized or wholly 
ignored through this approach.  The other strategy, to directly pay physicians to use 
EHRs, risks physicians purchasing electronic systems but never appropriately using them.   
Meaningful use, drafted and implemented by the HHS,  guides the disbursement 
for incentive funds to physicians, via Medicare and Medicaid, initially for EHR 
implementation and eventually, in later stages, for demonstrated improvement in clinical 
outcomes and quality measures.  The use of a broad portfolio of requirements, instead of 
simple reimbursement for the purchase of EHR, allows HITECH to promote broad 
functionality beyond clinical care - such public health monitoring and care quality 
reporting. 
Most other provisions of the HITECH act were are managed by the Office of the 
National Advisor of Health Information Technology (ONCHIT) and serve to support the 
 A2- 5 
 
actualization of meaningful use.  To overcome logistic and technical challenges of 
purchasing and implementing EHR, HITECH created a national network of regional 
extension centers (REC).  Mimicking a previously existing government program that 
assists farmers in staying current with agricultural technology, RECs provide hands-on 
intellectual support to providers in purchasing, implementing, and maintaining EHR 
systems. (Blumenthal 2011, 2323-2329) 
Too few HIT experts are available to support providers in transitioning to EHR 
use; in 2009, studies estimated that 50,000 additional health information technology 
professionals would be needed to match demand.(Rollins 2010, 28-34)  The HITECH act 
mandated that the ONC train a sufficient professional body to interact with vendors, 
providers, and REC to realize policy goals. (Blumenthal 2011, 2323-2329)  As a 
mechanism of consumer protection for providers newly adopting EHR, the bill required 
ONCHIT to establish and manage a certification process for meaningful use appropriate 
technology. 
The exchange of health information across platforms and providers is also a 
focus of the legislation.  ONCHIT was provided $300 million dollars to fund state level 
efforts in constructing regional information exchanges and $2 billion to construct a 
national health information exchange.  The exchanges must fulfill several functions 
including creating standards for compatibility, establishing and maintaining an 
information-sharing specific infrastructure, and reinforcing the adherence to established 
norms. 
Promoting information sharing increases the risk of breaching confidentiality; the 
HITECH act restructured existing HIPAA laws to be more robust and have greater 
consequence.  The maximum penalty for an episode of a negligent breach was increased 
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from $25,000 to $1.5 million and restrictions for the use of health information for 
marketing and fund-raising purposes were strengthened. 
 Initial Challenges of Implementation 
The scope and complexity of the HITECH act cannot be emphasized too 
strongly.  A country of such size, heterogeneity, and political decentralization as the U.S. 
faces significant challenges in the creation of a coordinated national exchange of health 
information.  The central provision of HITECH, Meaningful Use criteria, has no legal, 
political, or academic precedent.  The remaining programs of the HITECH act have to be 
created anew by a nascent political committee, ONCHIT, with very little legislative 
experience and within a timeline that is considered, by those that drafted the legislation, 
ambitious. (Stark 2010, 12) 
The secretary of Health and Human Services was required to draft meaningful 
use criteria, the standards for meaningful use appropriate technology, and the certification 
process to support those standards, within 10 months.  Given the lack of precedence and 
the policy’s far reaching scope, the timeline was challenging.  Similarly, the initial 
schedule for implementing MU criteria was rapid.  The criteria were to be released by 
December 31, 2009; hospitals could begin receiving MU reimbursements by October 1, 
2010 and professionals could receive payments by January 1, 2011.  Reimbursements 
were scheduled to significantly decrease by 2012 and end by 2016, frontloading the 
reimbursement schedule to encourage providers to rapidly adopt EHR. (Blumenthal 2011, 
2323-2329) 
Having the entire country purchase EHR is, alone, a challenging goal.  However, 
at the time the bill was passed, no infrastructure existed to support providers in acquiring 
EHRs and achieving meaningful use.  RECs had to be created and staffed, technicians 
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trained, and health information exchange programs developed.  The rapid timeline 
doesn’t allow for the refinement of the many programs being developed before they are 
scaled to a national level.   
Furthermore, the pace of meaningful use implementation and accompanying 
financial incentives threaten to redirect the development of HIT in an unproductive way.  
Providers will focus on implementing certified HIT to ensure full reimbursement, and 
vendors on modifying existing software to adhere to new meaningful use certification 
requirements.   The risk of severely redirecting provider and vendor energy is delaying 
the refinement clinically meaningful systems in favor of superficially modifying products 
with concerning usability issues in order to meet policy requirements. (Karsh et al. 2010, 
617-623) 
Meaningful Use 
Among the objectives of meaningful use are complex functions such as 
information exchange, electronic prescribing, and automated reporting of quality 
performance – lofty goals for a system still dominated by paper charting.  Many of the 
demonstrated cost and quality benefits of HIT have been associated with the use of 
decision support and information sharing (Wu et al. 2006, 742-752; Walker et al. 2005, 
5), and policy makers felt that requiring only the purchase of EHR would be inadequate 
to reap the potential benefits of widespread EHR implementation. (Stark 2010, 12) 
Incentives 
The drafting of the requirements for meaningful use are the responsibility of the 
HHS and the dispersion of incentive funds that CMS.  The initial bill authorized a 
disbursement of up to $44,000 for Medicare dominant providers and up to $63,750 for 
Medicaid dominant providers, each distributed over a 5 year period; hospitals were 
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offered from $2 to $10 million dollars.  The incentives are awarded in annual increments, 
the amount of each gradually reducing over several years, to finally terminate in 2015 for 
Medicare and 2017 for Medicaid. (Blumenthal 2011, 2323-2329) 
Criteria 
Meaningful use is planned to occur in three stages, each with increasingly 
demanding requirements.  The objective of stage 1 criteria is to promote the purchase of 
certified EHRs, the entry and reporting of structured data, and the development of an 
infrastructure to facilitate information sharing.  Later stages will progress to requiring bi-
directional exchange of information – with both other providers and patients - and 
eventually demonstrated improvements in quality, efficiency, and population health. 
Stage 1 involves approximately 25 criteria – the amounts vary slightly between 
physicians and hospitals – of which are a set of required “core” objectives and optional 
“menu” objectives.  Physicians, for example, must achieve all 15 core objectives and 5 of 
10 menu objectives to be eligible for the incentive payments; hospitals have only 14 core 
objectives but must also achieve 5 of 10 menu objectives.   Providers must demonstrate 
meaningful use by 2012 to be eligible for the full incentive amount; planned deadlines for 
stage 2 and stage 3 are 2013 and 2016 respectively and must each be met to continue to 
receive payments. 
Stage 2 Meaningful Use 
The Notice of Proposed Rule Making (NPRM) for Stage 2 of Meaningful Use 
was recently released by HHS and read by the Office of the National Coordinator of 
Health Information Technology (ONCHIT).  Some believe that meaningful use should be 
more aggressive, requiring the demonstration of clinical benefits, while other believe that 
the bar for meaningful use is already too high and should step back, offering incentives 
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for just acquiring EHRs. The changes and requirements in the NPRM demonstrate a 
balance of clear movement forward but also restraint to ensure that objectives remained 
feasible  achievable for most providers.   
The central thrust of meaningful use, from its inception, was to promote specific 
functionalities in addition to EHR adoption: computerized prescribing with decision 
support, quality reporting, and health information exchange.  To that, stage 2 rules stay 
true, incrementally increasing requirements in each of those three domains.   
1. Computerized provider order entry (CPOE) requirements have been raised to 
require that most orders occur electronically.   
2. A host of quality measures have been proposed for required reporting to 
achieve meaningful use.   
3. Stage 1 only required providers to purchase EHRs with the ability to 
information share, stage 2 requires that they actually use the functionality.   
A significant move forward, one that received attention from the ONC upon 
release of the NPRM, is the increased requirement for patients to access their own data.  
Previously, providers only needed to be able to provide patients an electronic copy of 
their health information upon request; the revised stage 1 and proposed stage 2 rules 
require that 50% of patients have the ability to view, download, and transmit their data 
and that 10% actually do so.   
The final rule may differ, as providers will likely object to being held 
accountable for a patient’s behavior, but regardless, it signifies the importance of 
technologies such as health portals or personal health records moving forward.  As 
subsequent revisions of meaningful use objectives shift to require electronic patient 
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access to health information, health portals will become increasingly ubiquitous and the 
line of inquiry into their utility will intensify. 
Personal Health Records 
 
Patient engagement and patient access to health information are becoming 
increasingly important concepts in an era of health care reform.  Patient centered medical 
homes, accountable care organizations, and new modifications to meaningful use 
objectives all embrace the importance of patients becoming more directly involved with 
their health care processes.  A recent HIT action agenda states that access to personal 
health information (PHI) ‘empowers patients to actively partner with their health care 
providers in making important health care decisions, which can potentially lead to better 
health care and better health outcomes.’ (Wilson C 2010)  Though data exist to 
demonstrate better health behaviors with patient engagement (Hibbard et al. 2007, 1443-
1463), no literature has yet to demonstrate an association between electronic access to 
health information and patient engagement. 
The American Health Information Management Association (AHIMA) defines 
Personal Health Records (PHR) as an “an electronic lifelong resource of health 
information needed by individuals to make health decisions.  Individuals own and 
manage own and manage the information in the PHR, which comes from health care 
providers and the individual.  The PHR is maintained in a secure and private 
environment, with the individual determining rights of access.  The PHR does not replace 
the legal record of any provider.” (AHIMA e-HIM Personal health Record Work Group 
2005, 1-7) The methods by which PHRs are filled with PHI vary.  Initial versions were 
populated manually by the patient, but more recent PHRs, “tethered” to a provider, 
automatically pull data from the provider’s records.  Personal health records can also 
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have additional functionality such as electronic communication with a provider, 
scheduling, and self-management tools.   
Patient portals are similar to PHRs in that they provide patients with online 
access to their PHI and also have additional functionalities such as scheduling and 
communication.  Portals, however, are often directly associated with a provider, where as 
a PHR is often independent and may interface with several providers.  Currently, the 
distinction between PHRs and portals, especially in the academic literature, is minimal.  
PHR seems to be the most inclusive and commonly used term, though the technology 
described within many PHR studies could just as easily be referred to as a patient portal - 
as most of the PHRs used in studies are directly associated with the researching 
institution. 
The current rates of PHR use by patients are modest.  Although most believe that 
a PHR would provide significant benefit in managing their health care, there are 
significant concerns about privacy and security. (Fuji, Galt, and Serocca 2008)   A study 
of a large health cooperative, which encouraged all patients to use PHR, observed a 42% 
signup rate but only 16% active use rate. (Yamin et al. 2011, 568)  Similar patterns of 
low registration and low utilization were observed in many of the recent studies of PHR 
and health portals.  The current low utilization is in contrast to consumer survey research 
which has shown growing interest in using PHRs. (Kaelber et al. 2008, 729-736) 
Most current research of PHRs has focused on cross-sectional explorations of 
PHR use, internet access, and patient attitudes toward PHRs. (Kaelber et al. 2008, 729-
736)  Newer literature has examined utility of PHRs in improving the clinical outcomes 
for specific chronic diseases.  The few randomized trials that have published did not 
demonstrate benefits clearly attributable to the use of a PHR. (Archer et al. 2011, 515-
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522; Tenforde, Jain, and Hickner 2011, 351-354)  Additionally, there remains a clear 
need to explore potential benefits on a systems level. (Archer et al. 2011, 515-522) 
Significant drivers for the political interest in health information technology are 
both its potential to improve the quality of care and reduce the cost of care.  The 
theoretical cost savings occur, not only on an individual level – with decision support 
tools - but on a systems level, through the prevention of unnecessary use of emergency or 
inpatient resources.  Many episodes of inpatient care are the exacerbations of chronic 
disease and preventable by improving access to primary care and improved care 
coordination. 
The emergency room has become known as a repository for failures in the health 
care system.  Inadequate disease management or poor access to primary care leads 
patients either to seek primary care in the emergency room or to need emergent care for a 
disease that could have been treated earlier in an ambulatory setting.  PHRs, especially 
those with secure messaging, constitute a form of increased access to a provider, but is it 
a type of access that is meaningful?  In giving a channel of constant communication to 
physicians and improved access to personal health information, do PHRs or patient 
portals have the ability to change care seeking behavior?   
Our study explores the utility of PHRs from a system perspective; in an adult 
population of family medicine patients, is having portal access, provided by a primary 
care practice, associated with a decrease in inappropriate emergency room visits? Our 
question touches on a topic that is both financially and clinically relevant and initiates an 
inquiry into a body of knowledge useful to large health care organizations dedicating 
significant resource toward the development of patient portal capacity. 
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Systematic Review Appendix 
 
Introduction 
  
The language surrounding health information technology, and specifically 
internet access to health information, is yet to be standardized.  Lay-language is common 
and multiple terms refer to the same concept.  A “patient portal” is a web page which 
allows a patient to access her health information.  This access can include recent lab 
reports or portions of the physician’s documentation.  Portals can also include additional 
functionalities such as secure messaging with a provider or online scheduling. 
Personal health records (PHR) are another relevant technology that provides 
patients with access to personal health information.  PHRs exist independent of a single 
provider and allow patients to store, manage, and share personal health information.  The 
method by which PHRs are populated with PHI vary; initially they existed separately of 
the clinician’s records and had to be filled in manually by patients, but more recently 
“tethered” PHRs automatically populate themselves from a provider’s records.  The 
information stored in a PHR is separate of the clinician’s records and does not replace 
any medical documentation.  PHRs can also include functionalities like secure messaging 
and scheduling.   
The line between a portal and a PHR are unclear.  The most significant 
differentiator of the two terms is that portals are associated with a single provider while a 
PHR is a separate third-party service.  In research however, most HIT systems used are 
affiliated directly with the institution performing the research.  The use of the term PHR 
rarely signifies a system that exists independently of a provider or a system that manages 
the health information of multiple providers.  The term PHRs appears to be the more 
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common and inclusive term in the literature - encompassing the portal concept – but 
thematically contiguous research is occurring under both terms.   
The most well developed body of literature in terms of portals is an examination 
of access, use, and attitudes. (Archer et al. 2011, 515-522)  Recently, there has been a 
move beyond this approach into examining portal use in a clinical context via clinical 
outcomes - however this body of research is comparatively new.  Though the focus of 
this systematic review is to explore system level research of portals, little literature exists 
on the topic. (Kaelber et al. 2008, 729-736; Nazi et al. 2010, 62-67) We have broadened 
the scope to capture the growing literature of clinically oriented research which will serve 
as a platform to extend into systems level research. 
 
Methods 
 
We searched MEDLINE database from January 2002 through May 2012 using a 
combined key word search of “(“personal health records” or “secure messaging” or 
“electronic messaging” or “patient portal” or “internet portal” or “web portal” or 
“online portal”) AND outcomes.”  We supplemented these sources by searching with the 
keywords “personal health record” and “secure messaging” in EMBASE and Web of 
Science as well as hand searching bibliographies.  The search was executed in May of 
2012 and returned 329 unique titles.  A single reviewer performed title reviews and 
abstract reviews of the initial search results based on predetermined inclusion and 
exclusion criteria (Table 1).  Of the articles remaining, the bibliographies were examined 
for additional articles; these articles were subjected to the same selection process as the 
initial search results.   
The search produced 7 studies for inclusion in the systematic review (Figure 1).  
We selected comparative studies examining the effect of secure-messaging or health 
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portal access on clinical outcomes or healthcare utilization and specifically excluded 
studies of custom-designed, internet-based clinical interventions - unless the primary 
medium of the intervention was the use of a PHR or health portal.  Using USPSTF 
methodology a single reviewer evaluated the selected articles and rated the quality of the 
study design on a three variable scale: good, fair, and poor.  We abstracted relevant 
information to be included in the systematic review and briefly commented on the 
strengths and weaknesses of each included article. 
 
Table 1: Selection Criteria 
 Inclusion Criteria Exclusion Criteria 
Study Design prospective or retrospective 
comparative studies; meta-analysis 
descriptive studies; systematic reviews; non-
systematic literature reviews 
Intervention Online access to tethered health 
information; access to secure 
messaging 
Untethered personal health records; provider 
facing HIT; educational programs delivered online; 
remote monitoring; tele-medicine 
Outcomes use of health services; disease specific 
outcomes 
use, attitudes, or access to information technology 
Population family medicine or internal medicine 
adult population 
Specialty-based; pediatric; inpatient 
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Figure 1: Systematic Review Flow Diagram 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Results: 382 
PUBMED: 75 
Web of Science: 25 
EMBASE: 273 
Hand-pulled: 9 
 Unique results: 329 
 
Title Review: 329 
 
 Eliminated: 277 
 
Abstract Review: 62 
 
Eliminated: 33 
Pediatric/Psychiatric Population: 4 
No clinical / utilization endpoint: 19 
No PHR/Portal intervention: 1 
Systematic Review/Descriptive study design: 9 
Full Review: 29 
Initial Search: 20 
Hand-pulled: 9 
 
Eliminated: 22 
Pediatric/Psychiatric Population: 3 
No clinical / utilization endpoint: 7 
No PHR/Portal intervention: 4 
Systematic Review/Descriptive study design: 8 
Studies for Inclusion: 7 
Initial Search: 3 
Hand-pulled: 4 
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Limitations 
 
We consciously compromised several components of a large-scale systematic 
review to maintain a project scope appropriate for our time and resource limitations.  The 
query was refined and focused to limit the volume of initial results.  A more extensive 
analysis would use broader search terms and place more emphasis on title and abstract 
review.  
Only a single reviewer evaluated titles and abstracts for inclusion; having a 
second independent reviewer and a set protocol for evaluating discordance between 
reviewers is an important facet of a thorough systematic review.  Similarly, though we 
used a standard method to assess the quality of studies, this evaluation was only done by 
one reviewer.  Having a second independent reviewer to evaluate a sample or all of the 
articles would strengthen the reliability of the quality assessments. 
We extracted 7 comparative studies of personal health records or secure 
messaging with clinical or healthcare utilization outcomes.  5 studies were randomized 
controlled trials, 1 was a retrospective cohort study, and 1 was a comparative analysis of 
cross-sectional data.  The current literature can be organized broadly by intervention: 
those that examine general access to PHRs and those that study custom-designed, 
disease-specific interventions delivered via a PHR.   
All studies were executed in an adult, outpatient setting.  All studies examined 
clinical markers for management of either hypertension or diabetes: systolic blood 
pressure, diastolic blood pressure, LDL cholesterol, or glycosylated hemoglobin 
(HbA1c).  One study tracked health care utilization in the form of clinical visits, both 
inpatient and outpatient. 
Access to Personal Health Records. Wagner et al. is the strongest study to date 
that examines the effects of PHR use in a clinical context.  Though the primary outcomes, 
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systolic and diastolic blood pressure, were not significantly different between the control 
and intervention arms, several aspects of the study provide insight into the null finding.  
The interest and utilization of PHR technology was low in the study; only 26% of 
potential participants agreed to participate – the most commonly sighted reason being 
lack of interest.  Of the participants randomized to the intervention, utilization was still 
inconsistent; 54% used the PHR less than 2 times in 9 – 12 months.   
A subgroup analysis demonstrated an association between more frequent PHR 
use and a significant decrease in BP.  The association could suggest the presence of a 
threshold “dose” of PHR use required to generate clinical change or could merely be an 
association confounded by an overall drive to engage on the part of the patient.  Patients 
with low baseline activation also demonstrated low PHR use and those with high baseline 
activation demonstrated high PHR use – suggesting that activation could be a moderator 
of use.  Higher use of PHR was also noticed in association with greater provider-patient 
communication. 
Teneford et al. used an observational study design which allowed a larger sample 
size and also measured frequency of portal use to examine a potential dose-response 
relationship between portal use and outcomes.  The baseline characteristics of the 
intervention and non-intervention group varied significantly on important variables; 
portal users were generally healthier, wealthier, younger, more educated, and more likely 
to identify as Caucasian.  After adjusting statistically for measured differences, small 
benefits were observed with several diabetes quality measures though the differences 
were likely not clinically significant.  However, the study did not measure a baseline 
level of engagement, which is a significant confounder – the measurement and 
adjustment of which would likely shift findings toward the null. 
The study also recorded frequency of use and observed two significant patterns: 
there were clinically significant differences between non-users and users of at least one 
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day; clinical outcomes changed only slightly with frequency of use – a 10 day increase 
was associated with a clinically insignificant change in HbA1c (0.02%, p<0.01).  The 
data did not clarify if portal access provided a benefit independent of engagement or was 
only a marker for a more engaged patient.  The lack of significant dose response 
relationship suggests the latter is more likely true and portal access, in its current form, 
does not significantly changing health outcomes. 
Shaw and Ferranti et al. found that portal use was not a predictor of LDL or total 
cholesterol levels.  There was a small, statistically significant, unadjusted difference in 
HbA1c between the two groups for both Type I (portal: 7.89, non-portal: 8.16, p<0.0001) 
and Type II diabetes (portal: 7.19, non-portal: 7.39, p<0.0001).  The analysis showed no 
correlation between amount of portal use and clinical outcomes.  The study design and 
analysis did not adjust or capture potential confounders and was unable to determine if 
the clinical difference could be attributed to portal use or was an artifact of other, 
unmeasured differences between the groups – such as baseline engagement. 
Portal based interventions. Grant et al. published an RCT which examined a 
diabetes mellitus (DM) specific intervention delivered via a web-portal-like interface.  
Participants viewed DM related laboratory data, answered questions about concerns or 
barriers, and received custom generated care plans.  The study used an active control, 
access to the portal and non-DM-specific health information.  The difference between the 
control and intervention arm was the content made available through the portal rather 
than portal access itself. 
The study had several challenges; though many patients were approached only 
few agreed to join the study (6797 approached, 244 enrolled).  The two arms of the study 
appeared roughly comparable, but there were significant demographic differences 
between study participants and the general population.  The low enrollment and 
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participation rates limited the power of the study, and statistical analysis was limited to 
exploratory, unadjusted bivariate analysis. 
Of those participants in the intervention arm, 51% submitted a “care plan” via the 
portal; those that submitted a care plan were more likely to have a medication adjustment 
compared to the control group (29% vs 15%, p=0.10), and those that had medication 
adjustment had a significant unadjusted decrease in HbA1c (0.57% [%1.00], paired t-test 
p=0.009) and LDL-C (32.1[31.9] mg/dl; paired t test p=0.02) 
The findings of the study are limited.  In a select population subgroup, likely one 
that is highly engaged at baseline, only a percentage actively participated by submitting 
care plan and of that group only a percentage altered their medication which was 
associated with a modest improvement in DM outcome measures.  Concerned about 
physicians resisting an intervention that required more time or investment, the study did 
not specifically train doctors or patients nor did it require that participating physicians 
change their care routine. 
Ralston et al used an RCT to examine a PHR based intervention that involved 
both access to a PHR as well as personal consultations with a case manager.  The study 
did demonstrate a significant decrease in HbA1c (-0.7%; p = 0.01) with the intervention 
but did not demonstrate significant change in other clinical outcomes – total cholesterol 
and blood pressure - or healthcare utilization.  The intervention group had a greater 
prevalence of HbA1c < 7.0% after 12 months (33% vs 11%; p=0.03). 
The study design was limited in that the control group had neither access to a 
portal nor counseling by a case manager.  The observed beneficial effects of the 
intervention cannot be attributed to the use of the portal per se as they are unable to be 
distinguished from the effect of the personal case manager.  Healthcare utilization was 
not a primary outcome nor was the study powered to detect a meaningful difference.  An 
exploratory analysis did not demonstrate correlation between decreased healthcare 
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resource use and portal use though the small sample size makes the observation far from 
conclusive. 
Green et al. is another RCT that examines a hypertension specific intervention.  
The study has three arms: usual care, web training with home monitoring, and web 
training, home monitoring and web based communication with a pharmacist.  All 
participants were given an account to a health portal which had several functionalities 
including viewing labs and secure messaging with providers.  The difference of the 
intervention is the use of home monitoring and web communication with a pharmacist – 
rather than access to a PHR or secure messaging. 
The web training consisted of a brief personal tour of the web based services 
offered by the portal.  Participants of the second arm of the study, those with home 
monitoring and web portal training, demonstrated a non-statistically significant trend 
towards clinical improvement, a greater portion of the intervention had controlled 
hypertension compared to the control group (RR  1.2; 95% CI, 0.95 – 1.56). The 
pharmacist based arm did demonstrate statistically and clinically significant improvement 
in both systolic and diastolic blood pressure as well as portion of the population with 
controlled hypertension compared to the control (RR 1.84; 95% CI, 1.48 – 2.29).   
Similar to Grant et. al the study did not isolate access to a portal as the 
intervention but rather examined different methods of using a portal.  Though the study 
was well designed to show that web based communication with a pharmacist can be 
beneficial, it is unclear if similar or better outcomes would be realized with a telephone or 
face-to-face interaction with a pharmacist.  Additionally, the inclusion criteria limited the 
study to a very select sub-population that is likely to be more engaged at baseline.  
Though the study did provide insight into the use of a multi-disciplinary team to managed 
chronic disease it did not clarify the underlying question “does the use of a PHR or 
secure-messaging provide a distinct benefit?” 
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Discussion 
 
Within the current PHR literature there is an even distribution of observational 
and randomized control studies, which either examine general portal access or a disease 
specific intervention using a health portal as a channel for delivery.  Methodological 
challenges and nuances in study design have made the evidence of PHR utility in a 
clinical context inconclusive. 
A common challenge to all PHR studies is the relationship between patient 
engagement and likelihood to use a PHR.  The hypothetical causal path for PHRs is 
utilization increases engagement which in turn generates healthier behavior and better 
outcomes.  In practice, however, it is likely that patients more engaged with their care are 
also more likely to use a health portal; engagement is a moderator, not an outcome, of 
portal use.  It is likely that a combination of both is true, engaged patients are more likely 
to use a portal but portal use also improves engagement.   
Without a measure of baseline engagement there is no way to distinguish the 
confounding relationship from the causal.  Most studies did not measure engagement or 
account for it with a proxy; the one study that did measure engagement, Wagner et al., 
did not demonstrate statistically significant changes in primary clinical outcomes.  In 
observational studies the different study groups demonstrated significant differences 
across several demographic variables – portal users were generally wealthier, more 
educated, younger, and whiter.  The differences in measured variables suggest that 
differences in unmeasured variables – such as engagement – exist as well.  Regardless, 
changes in clinical outcomes were modest, lacked clinical significance, and were unable 
to be differentiated from the effect of potential confounders. 
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Randomized controlled trials, though better able to isolate the effect of the 
intervention, had limited generalizability.  Most trials enrolled only a small percentage of 
a large group of potential participants.  Amongst the reasons for non-participation, lack of 
interest or lack of internet access were cited frequently - in the study by Wagner et al. 
lack of interest or access accounted for approximately 20% of all exclusions.  Extensive 
exclusion criteria have the benefit of creating an ideal environment to examine the effect 
of an intervention – more of the participants are engaged in their care and willing to use 
additional services.  Any benefits demonstrated in such a carefully selected subgroup will 
provide little insight into the utility of the intervention in widespread practice.  The low 
participation in studies and low utilization of PHR services during the studies contrast 
with prior surveys demonstrating a clear interest in electronic access to health 
information on the part of patients.   
Active Control Studies.  A few studies, in an attempt to eliminate the 
confounding effect of higher engagement in portal users, used an active control (Grant et 
al. 2008, 1776; Green et al. 2008, 2857; Ralston et al. 2009, 234-239) in which the 
control arm was given access to the portal.  Additionally, the studies provided specialized 
content or management by a non-physician provider to the intervention group. The 
difference between the arms was content delivered via the portal, rather than portal 
access itself.  
Though several active control studies did demonstrate clinically significant 
benefits, the multi-faceted nature of the interventions made researchers unable to attribute 
the benefit to portal use.  Theoretically, if randomization is adequate, an active control is 
unnecessary, as baseline engagement – or lack thereof – would be equally distributed 
between the study groups.  The use of active controls, instead of providing a more 
insightful look at the effect of a portal, effectively controlled for the effect of the portal.  
Benefits observed in the active control studies, some of the most significant of the health 
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portal literature, occurred despite portal use, not because of it.  No studies suggest if 
better, same, or worse outcomes would occur if similar, multi-faceted interventions, were 
delivered in person or through another medium. 
Low utilization.  Studies which had a recruitment processes were significantly 
challenged by low baseline interest in participation. (Ralston et al. 2009, 234; Shaw and 
Ferranti 2011, 714-8; quiz 719-20; Wagner et al. 2012) In the hypertension study by 
Wagner et al. only 26% of those approached consented to be enrolled in the study, the 
most common reason for exclusion was patient disinterest (44%).   Even among the 
minority of candidates that decided to participate in the studies, a cohort much more 
likely to be engaged compared to the general population, many studies noted low overall 
utilization.  Teneford et al. observed median portal use rates of less than once a month 
and the majority (54%) of participants in the Wagner et al. study only used the portal 1 – 
2 times in a 12 month period. 
Lack of clear dose-response relationship.  Several trials, as a secondary 
outcome, examined frequency of portal use as a predictor for clinical outcomes.  In most 
studies, no significant linear relationship was observed though a few patterns did emerge.  
Teneford et. al observed a significant difference in health outcomes between non-users 
and those that used a portal at least once but no linear relationship between amount of use 
and clinical outcomes.  Wagner et. al observed a difference in outcomes between the 
average user and those that were high-frequency users – even after controlling for 
baseline patient engagement - suggesting a threshold dose-response effect.  Other studies 
which measured use did not have similar findings. 
The two threshold effects could indicate a benefit related to the portal but could 
also merely be indicators of intrinsic patient engagement.  The absence of a correlation 
between frequency of use and outcomes weakens the probability of the observed benefits 
being caused by portal access. 
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 Length of study and outcomes.  Most studies were limited to approximately one 
year and had little follow-up after completion of the intervention.  It is uncertain if 
patient’s interest in the portal will fade after time or if patients will permanently shift the 
channels through which they seek care.   Even if portals can be demonstrated to change 
clinical indicators, such as HbA1c and blood pressure, these are only intermediate 
measures of health.  The longevity and consistency of use of the portal are critical 
mediators for demonstrated short-term reductions in clinical measures to translate to 
patient relevant benefits.  No studies demonstrated or even suggested PHR use has the 
ability to meaningfully change the incidence of patient relevant morbidity and mortality: 
death, MI, symptomatic retinopathy, peripheral vascular disease, etc.  
Provider role.  Few studies addressed the role of a provider, either as a part of the 
intervention or as a noted element of the environment in which the study occurred.  Grant 
et al. measured patient-provider interaction and observed a strong correlation between 
provider communication and portal use.  Wagner et al. failed to demonstrate benefit with 
a portal based intervention; in the discussion they mentioned that, because of the general 
lack of provider willingness to engage, there was no specific provider training nor were 
providers requested to modify their care processes in any way. 
In Green et al. a pharmacist communicated with patients via secure-messaging as 
part of the intervention.  Though the median portal use in the control arm was low (1 – 2 
uses over 12 months) the portal use for the intervention arm, those being managed 
actively by a pharmacist, was much higher (20 uses in 12 months). (Green et al. 2008, 
2857)  A majority of the portal uses in the intervention group were initiated by the 
managing pharmacist. 
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Conclusion 
 
The language surrounding PHRs is idealistic, it is touted as bedrock for the future 
for providing high-quality and cost effective care.  Additionally, literature exists which 
suggests the desire for and access to health information online. (Archer et al. 2011, 515-
522; Shaw and Ferranti 2011, 714-8; quiz 719-20; Fuji, Galt, and Serocca 2008)  
However, the most recent studies examining the clinical utility of PHRs have had mixed 
and limited results.  Even of those studies that did demonstrate clinically significant 
findings, the multifaceted nature of the interventions or the specifics of the study design 
make it difficult to know if the observed benefits could be attributed to the use of a PHR. 
The heterogeneity of the results seems to be related two broad themes: patient 
disparities and provider engagement.  Portal access in isolation seems to provide little 
meaningful benefit; however provider engagement with patients (Wagner et al. 2012) or 
proactive patient communication by team members via a portal (Green et al. 2008, 2857) 
appear to improve utilization and are associated with better outcomes. 
The studies thus far have significant variation both in design and results.  The 
current challenge is to more thoughtfully examine why similar interventions have 
differing outcomes.  Technology, in most cases, is only a tool.  If used properly it can 
improve a process, if used inappropriately, it can be a hindrance; it has little demonstrated 
implicit value.  Though there is a lack of significant findings with most primary outcomes 
in most studies, the secondary outcomes and measures of portal use provide compelling 
exploratory data suggesting that PHR implementation itself has significance and other, 
currently unexamined, variables, such as the provider’s level of PHR engagement, may 
be critical mediators in the clinical benefit of PHR technology. 
Those few studies with demonstrated clinical value often had proactive 
communication with the patient through the portal or improved portal use associated with 
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greater patient-provider communication; conversely, a study that was well-executed but 
did not require providers to change care processes demonstrated no significant benefit to 
the patient.  No studies were specifically designed to isolate the role of the provider in 
moderating the clinical benefit of PHRs; at this point such observations are mostly 
speculative, informed by non-primary outcomes of a few studies, but still, they are 
suggestive enough to highlight the importance of considering the provider role.  
Additionally, it is intuitive that the providers perception and use of PHR technology 
would in some way influence the utility of the portal for the patient.  The several multi-
faceted intervention studies demonstrate that a patient portal can be a viable channel for 
clinically beneficial care processes.  It is unclear if portals, as a medium for care, are 
neutral to, detract from, or amplify the effect of the intervention if it were delivered 
through a more traditional face-to-face interaction. 
Future research.  Studying PHR implementation has similar methodological 
issues to much quality improvement research: there is a strong cultural component to the 
implementation.  Cultural variables such as physician attitudes and proactive utilization 
by the care team of new channels of care are likely important.  Early attempts to engage 
in focused randomized trials have been largely unsuccessful in demonstrating meaningful 
benefit.  A mixed methods study, exploring provider engagement in tandem with tracking 
clinical outcomes, would inform future studies of important currently unaddressed 
confounders and help clarify the role of a portal in permitting or enhancing patient 
engagement. 
Studies of multi-faceted, portal-based interventions, especially those that engage 
non-clinician providers, need to design studies that isolate the portal as an intervention to 
help more clearly delineate the effect of the portal as a medium for care.  For example, a 
new study could have three arms: usual care, usual care with medication management by 
a pharmacist in person, or usual care with medication management by a pharmacist via a 
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web portal.  Such a study, especially if combined with mixed methods could explore both 
the clinical utility of the portal as well as the quality of the experience both for patients 
and providers. 
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Study Design Data 
Collection 
Technology Disease Outcome Key Finding Strengths Weaknesses Quality 
(Wagner et al. 
2012) 
RCT Not stated PHR access HTN BP No statistically significant 
difference was found 
between the intervention 
and control group.  A change 
in SBP and DBP was noticed 
in the most frequent users of 
PHR but it is not possible to 
determine if this is due to the 
intervention or self-directed 
health engagement.  PHR 
presence itself had no 
discernible effect on clinical 
outcomes. 
Adequate 
randomization and 
PHR focused 
intervention.  
Measured 
frequency of portal 
use.  Accounted for 
baseline 
engagement of 
patients. 
- Good 
(Shaw and Ferranti 
2011, 714-8; quiz 
719-20) 
Cross-
sectional 
analysis, 
secondary 
analysis of 
data 
1/11/2009 Patient portal 
access 
Diabetes HbA1c, LDL, 
Total 
Cholesterol 
Differences in A1C were 
observed between portal and 
non-portal users in both Type 
I DM - 7.89 and 8.16 for 
portal and non-portal users 
respectively - and Type II DM 
- 7.19 and 7.39 respectively. 
- The study only 
provided a crude 
analysis and did not 
capture or control 
for multiple 
confounders 
Poor 
 
(Tenforde et al. 
2011) 
Retrospectiv
e Audit 
1/7/2008 – 
1/6/2009 
PHR access Diabetes HbA1c, LDL, 
BP 
The study uniquely explored 
the level of engagement - 
quantified in times per 
month the PHR was accessed 
- and its effect on DM II 
outcomes.  Statistically 
significant decreases were 
seen in PHR users: HbA1c (-
0.29%), SBP (-1.13%), DBP (-
0.54%).  However, the 
changes were unlikely 
clinically significant and there 
was no meaningful 
relationship between extent 
of PHR use and clinical 
outcomes. 
The study 
measured and 
controlled for 
baseline 
engagement.  A 
large sample size 
provided adequate 
power to detect 
small differences.  
Conclusions were 
appropriately 
interpreted with 
regard to study 
design limitations 
The observational 
study design 
creates a high 
probability of 
selection bias. 
Fair 
 
(Ralston et al. 
2009, 234-239) 
RCT 1/8/2002 – 
1/5/2004 
PHR based 
intervention 
DMII, 
health care 
utilization 
HbA1c, 
outpatient  
visits, 
inpatient 
visits, 
inpatient 
days 
The mean HbA1c of the 
intervention group decreased 
(-0.7%, p=0.01) when 
adjusted for sex, age, and 
initial HbA1c - no confidence 
intervals provided.  No 
statistically significant 
changes in health care 
utilization were noted. 
- Statistically 
significant 
differences were 
noted between the 
two study arms.  
Limited statistical 
adjustment for 
demographic 
differences. 
Fair 
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(Green et al. 2008, 
2857-2867) 
RCT 1/6/2005 – 
1/3/2007 
Secure 
messaging 
based 
intervention 
HTN BP The intervention group did 
demonstrate a statistically 
and clinically significant 
decrease of SBP and DBP.  
Several design study issues 
mitigate this finding 
however, the most important 
of which is the intervention 
was a dual intervention: web 
messaging and pharmacist 
access.  The control group 
had neither.  Such a 
significant drop is most likely 
attributable to the 
pharmacist expertise than 
the use of secure messaging 
as a form of communication. 
- Multiple 
simultaneous 
intervention 
strategies make it 
difficult to attribute 
results to PHR use.  
Dual intervention  
Fair 
 
(Grant et al. 2008, 
1776) 
RCT 1/9/2005 – 
1/3/2007 
PHR based 
intervention 
DMII HbA1c No statistically significant 
difference was noted 
between intervention group 
and control group.  The study 
used an active control design; 
both the intervention arm 
and the control arm were 
using PHR: the difference was 
content, rather than channel 
of delivery. 
- Study design did 
not isolate PHR as 
an intervention. 
Poor 
 
(Holbrook et al. 
2005, 982) 
RCT Not stated PHR based 
intervention 
DMII HbA1c, BP A statistically significant 
difference was noted with 
HbA1c (-0.2%, p=0.001) - 
confidence interval not 
provided.  DBP also 
decreased: -2.68 mmHg, 
p=0.007, confidence interval 
not provided. 
- Poor reporting of 
study design 
hinders a reliable 
analysis of the 
study quality. 
Poor 
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